Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
Turkey
· Delayed Price · Currency is TRY 29.62
-0.82 (-2.69%)
At close: Apr 28, 2026
IST:MEDTR Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | 2,874 | 2,741 | 2,097 | 1,596 | 375.93 | Upgrade
|
| Revenue Growth (YoY) | 4.83% | 30.74% | 31.40% | 324.48% | 4.62% | Upgrade
|
| Cost of Revenue | 2,049 | 1,711 | 1,203 | 936.41 | 216.75 | Upgrade
|
| Gross Profit | 824.69 | 1,031 | 894.15 | 659.33 | 159.18 | Upgrade
|
| Selling, General & Admin | 677.45 | 615.03 | 416.51 | 241.54 | 66.76 | Upgrade
|
| Research & Development | 29.28 | 30.29 | 20.07 | 6.54 | 2.45 | Upgrade
|
| Other Operating Expenses | 11.72 | 81.12 | 79.02 | 25.38 | 0.88 | Upgrade
|
| Operating Expenses | 718.44 | 726.44 | 515.6 | 273.46 | 70.09 | Upgrade
|
| Operating Income | 106.24 | 304.34 | 378.55 | 385.87 | 89.09 | Upgrade
|
| Interest Expense | -47.36 | -96.55 | -76.1 | -39.68 | -13.37 | Upgrade
|
| Interest & Investment Income | 189.97 | 83.87 | 220.51 | 48.87 | 19.44 | Upgrade
|
| Earnings From Equity Investments | -21.58 | -16.16 | -10.49 | -1.97 | -0.5 | Upgrade
|
| Currency Exchange Gain (Loss) | 62.4 | 133.71 | 162.13 | 190.45 | 107.6 | Upgrade
|
| Other Non Operating Income (Expenses) | -305.77 | -311.24 | -594.35 | -387.57 | -0.16 | Upgrade
|
| EBT Excluding Unusual Items | -16.1 | 97.96 | 80.26 | 195.96 | 202.1 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -2.93 | - | - | - | Upgrade
|
| Pretax Income | -16.1 | 95.03 | 80.26 | 195.96 | 202.1 | Upgrade
|
| Income Tax Expense | -4.36 | 2.98 | 42.85 | 81.66 | 34.4 | Upgrade
|
| Earnings From Continuing Operations | -11.73 | 92.05 | 37.41 | 114.3 | 167.7 | Upgrade
|
| Minority Interest in Earnings | 2.46 | 4.06 | -0.06 | 0.03 | - | Upgrade
|
| Net Income | -9.27 | 96.11 | 37.35 | 114.34 | 167.7 | Upgrade
|
| Net Income to Common | -9.27 | 96.11 | 37.35 | 114.34 | 167.7 | Upgrade
|
| Net Income Growth | - | 157.37% | -67.34% | -31.82% | 177.53% | Upgrade
|
| Shares Outstanding (Basic) | 119 | 119 | 119 | 119 | 119 | Upgrade
|
| Shares Outstanding (Diluted) | 119 | 119 | 119 | 119 | 119 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 25.93% | Upgrade
|
| EPS (Basic) | -0.08 | 0.81 | 0.31 | 0.96 | 1.41 | Upgrade
|
| EPS (Diluted) | -0.08 | 0.81 | 0.31 | 0.96 | 1.41 | Upgrade
|
| EPS Growth | - | 160.54% | -67.71% | -31.85% | 120.30% | Upgrade
|
| Free Cash Flow | 250.79 | 534.54 | 501.56 | -43.66 | 27.72 | Upgrade
|
| Free Cash Flow Per Share | 2.11 | 4.49 | 4.21 | -0.37 | 0.23 | Upgrade
|
| Dividend Per Share | - | 0.252 | 0.294 | - | - | Upgrade
|
| Dividend Growth | - | -14.29% | - | - | - | Upgrade
|
| Gross Margin | 28.70% | 37.60% | 42.64% | 41.32% | 42.34% | Upgrade
|
| Operating Margin | 3.70% | 11.10% | 18.05% | 24.18% | 23.70% | Upgrade
|
| Profit Margin | -0.32% | 3.51% | 1.78% | 7.17% | 44.61% | Upgrade
|
| Free Cash Flow Margin | 8.73% | 19.50% | 23.92% | -2.74% | 7.38% | Upgrade
|
| EBITDA | 273.3 | 418.22 | 448.77 | 431.95 | 100.13 | Upgrade
|
| EBITDA Margin | 9.51% | 15.26% | 21.40% | 27.07% | 26.63% | Upgrade
|
| D&A For EBITDA | 167.06 | 113.89 | 70.22 | 46.08 | 11.04 | Upgrade
|
| EBIT | 106.24 | 304.34 | 378.55 | 385.87 | 89.09 | Upgrade
|
| EBIT Margin | 3.70% | 11.10% | 18.05% | 24.18% | 23.70% | Upgrade
|
| Effective Tax Rate | - | 3.14% | 53.39% | 41.67% | 17.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.